Skip to main content
OpenTrials

Clinical trial condition

Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8

Explore clinical trials studying Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 trial results

Active, Not Recruiting

Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)

NCT04595747

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +15 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
View all 18 locations
View Trial Details

Related conditions